spravato depression - Search News

Johnson & Johnson's Spravato nasal spray okayed

PopSugar · 14h

Can a Nasal Spray Really Help Treat Depression? Here's What to Know About Spravato

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Hosted on MSN · 4h

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.

J&J’s Spravato Makes Headway in Tough Depression Space With Monotherapy Approval

Esketamine, the active ingredient in Spravato, is a non-selective, non-competitive antagonist of the NMDA receptor, a known ...

GlobalData on MSN1d

J&J’s Spravato receives FDA label expansion for depression monotherapy

The FDA’s decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results